Company Filing History:
Years Active: 2019-2024
Title: Christoph Kannicht: Innovator in Glycosylated Proteins
Introduction
Christoph Kannicht is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of glycosylated proteins. With a total of four patents to his name, Kannicht's work focuses on enhancing the pharmacokinetics of fusion proteins and modulating immune responses.
Latest Patents
One of Kannicht's latest patents is titled "Glycosylated VWF fusion proteins with improved pharmacokinetics." This invention involves a fusion protein that includes a main protein and one or more extension peptides. The main protein is preferably von Willebrand factor (VWF), and the extension peptide contains a cluster of O-glycosylated amino acids. This fusion protein exhibits an increased half-life compared to the main protein, which can be beneficial for increasing the half-life of binding partners such as FVIII. Additionally, he has developed a patent for "Polypeptides modulating SIGLEC dependent immune responses." This invention relates to glycosylated polypeptides that show increased binding affinity to specific SIGLECs, which are important in immune response modulation.
Career Highlights
Christoph Kannicht is currently associated with Octapharma AG, a company known for its focus on human proteins and innovative therapies. His work at Octapharma has allowed him to contribute to advancements in therapeutic proteins, particularly in the context of hemophilia and immune disorders.
Collaborations
Kannicht collaborates with notable colleagues such as Stefan Winge and Guido Kohla. Their combined expertise enhances the research and development efforts at Octapharma, leading to innovative solutions in the field of biopharmaceuticals.
Conclusion
Christoph Kannicht's contributions to the field of glycosylated proteins and his innovative patents highlight his role as a key inventor in biochemistry. His work continues to impact therapeutic developments, showcasing the importance of innovation in healthcare.